Related Experiment Videos
Antibody therapy targeting CD19 for B-cell non-Hodgkin's lymphoma
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Tirabrutinib hydrochloride for B-cell lymphomas.
Drugs of today (Barcelona, Spain : 1998)·2021
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.
Cardiovascular research·2026
Gradually Enlarging Nodular Pulmonary Amyloidosis Associated With Sjögren's Syndrome.
Respirology case reports·2026
A Case of Thyroid Dermopathy.
Cureus·2026
Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities.
Journal of translational autoimmunity·2026